Literature DB >> 30593918

MiR-34c Ameliorates Neuropathic Pain by Targeting NLRP3 in a Mouse Model of Chronic Constriction Injury.

Lijuan Xu1, Qixing Wang1, Wei Jiang1, Shunzhi Yu2, Shouqin Zhang3.   

Abstract

MicroRNAs have been reported to be an important pathophysiological factor in neuropathic pain. However, the potential mechanism through which miRNAs function in neuropathic pain remains unclear. The purpose of this study was to explore the potential role of mir-34c in neuropathic pain in a mouse model of chronic constriction injury (CCI). We found that overexpression of miR-34c greatly alleviated CCI-induced neuropathic pain and spinal cord infarction, and reduced cell apoptotic and inflammatory cytokine expression in CCI mice. We also demonstrated that miR-34c suppressed the expression of NLRP3 by directly binding the 3'-untranslated region. Overexpression of miR-34c decreased the protein levels of NLRP3, ASC, caspase-1, IL-1β, and IL-18 in the spinal cord in CCI mice. Together, our results indicated that miR-34c may inhibit neuropathic pain development in CCI mice through inhibiting NLRP3-mediated neuroinflammation.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NLRP3 inflammasome; chronic constriction injury; miR-34c; neuropathic pain

Mesh:

Substances:

Year:  2018        PMID: 30593918     DOI: 10.1016/j.neuroscience.2018.12.030

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

Review 1.  MicroRNAs in the Spinal Microglia Serve Critical Roles in Neuropathic Pain.

Authors:  Simin Tang; Huan Jing; Fuhu Song; Haicheng Huang; Wenjun Li; Guiling Xie; Jun Zhou
Journal:  Mol Neurobiol       Date:  2020-09-09       Impact factor: 5.590

2.  Silencing of Long Noncoding RNA Growth Arrest-Specific 5 Alleviates Neuronal Cell Apoptosis and Inflammatory Responses Through Sponging microRNA-93 to Repress PTEN Expression in Spinal Cord Injury.

Authors:  Yuanwu Cao; Chang Jiang; Haodong Lin; Zixian Chen
Journal:  Front Cell Neurosci       Date:  2021-05-14       Impact factor: 5.505

Review 3.  Interactions Among lncRNAs/circRNAs, miRNAs, and mRNAs in Neuropathic Pain.

Authors:  Ge Song; Zheng Yang; Jiabao Guo; Yili Zheng; Xuan Su; Xueqiang Wang
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

4.  Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors.

Authors:  Christine Miaskowski; Kimberly Topp; Yvette P Conley; Steven M Paul; Michelle Melisko; Mark Schumacher; Margaret Chesney; Gary Abrams; Jon D Levine; Kord M Kober
Journal:  J Neuroimmunol       Date:  2019-08-02       Impact factor: 3.478

5.  MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1.

Authors:  Li Tu; Ping Xu; Xiang Long; Weidong Song; Zhongdong Lv; Huadong Zeng; Tiezhu Wang; Xianglu Liu; Juanni Dong
Journal:  Onco Targets Ther       Date:  2019-07-16       Impact factor: 4.147

Review 6.  The NLRP3 inflammasome: an emerging therapeutic target for chronic pain.

Authors:  Ruixiang Chen; Chengyu Yin; Jianqiao Fang; Boyi Liu
Journal:  J Neuroinflammation       Date:  2021-03-30       Impact factor: 8.322

7.  CY-09 Inhibits NLRP3 Inflammasome Activation to Relieve Pain via TRPA1.

Authors:  Youjia Fan; Gaici Xue; Qianbo Chen; Ye Lu; Rong Dong; Hongbin Yuan
Journal:  Comput Math Methods Med       Date:  2021-08-14       Impact factor: 2.238

Review 8.  Advances With Non-coding RNAs in Neuropathic Pain.

Authors:  Cheng Hu; Menglin He; Qian Xu; Weiqian Tian
Journal:  Front Neurosci       Date:  2021-12-23       Impact factor: 4.677

Review 9.  A Fatal Alliance between Microglia, Inflammasomes, and Central Pain.

Authors:  Stefanie Hoffmann; Cordian Beyer
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

10.  Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury.

Authors:  Pei Liu; Jianjun Chen; Shuai Ma; Jianjun Zhang; Jianyu Zhou
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.